C84.Z8
Other mature T/NK-cell lymphomas, lymph nodes of multiple sites
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code C84.Z8 refers to a category of lymphomas known as other mature T-cell and NK-cell lymphomas that involve multiple lymph node regions. These are types of blood cancers originating from specific immune cells called T lymphocytes (T-cells) and natural killer cells (NK cells). Unlike some lymphomas confined to a single lymph node region, this classification indicates a more widespread disease affecting several lymph node groups throughout the body. Recognizing this condition involves understanding its causes, presentation, diagnosis, and potential treatment approaches.
Causes & Symptoms
Clinical Causes: Genetic mutations altering lymphocyte behavior and growth Chronic immune stimulation or inflammation Viral infections, such as Epstein-Barr virus (EBV), associated with some lymphoma cases Environmental exposures, including certain chemicals and toxins Underlying immune system dysfunction or immunodeficiency states
Key Symptoms: Swelling or painless lumps in multiple lymph node regions, such as neck, armpits, or groin Unintentional weight loss Persistent fever or night sweats Fatigue or weakness Loss of appetite Generalized itching (pruritus) Potential symptoms related to affected organs, depending on disease spread
Diagnostic & Treatment
Diagnosis Path: Physical examination to assess lymph node swelling and other symptoms Imaging studies, such as CT scans or PET scans, to identify the number and location of affected lymph nodes Lymph node biopsy for histopathological analysis to determine cell type and malignancy Immunophenotyping through immunohistochemistry and flow cytometry to characterize T-cell or NK-cell markers Laboratory tests, including blood counts and other blood chemistry panels Bone marrow biopsy, if indicated, to assess for marrow involvement
Treatment Protocols: Chemotherapy regimens aimed at targeting high-grade lymphomas Immunotherapy, such as monoclonal antibodies, to enhance immune response against cancer cells Targeted therapies designed for specific molecular abnormalities Radiation therapy for localized disease or symptom relief Stem cell or bone marrow transplantation in select cases, particularly for advanced or refractory disease Supportive care to manage symptoms and prevent complications
Clinical Advice & FAQs
Billing Guidance
Is C84.Z8 a billable ICD-10 code?
Yes, C84.Z8 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C84.Z8?
Clinical documentation must specify the nature of Other mature T/NK-cell lymphomas, lymph nodes of multiple sites and any associated comorbidities for accurate reporting.
Cite this Clinical Reference